The Socioeconomic Impact of Narcolepsy NARCOLEPSY

[1]  Eduardo Martínez-Vila,et al.  The Cost of Stroke , 2003, Cerebrovascular Diseases.

[2]  M. Krom,et al.  The costs of epilepsy in three different populations of patients with epilepsy , 2003, Epilepsy Research.

[3]  M. Thorpy,et al.  Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies , 2003, Psychopharmacology.

[4]  G. Mayer.  Ritanserin Improves Sleep Quality in Narcolepsy , 2003, Pharmacopsychiatry.

[5]  T. Scammell,et al.  The neurobiology, diagnosis, and treatment of narcolepsy , 2003, Annals of neurology.

[6]  S. Brooks,et al.  Novel therapies for narcolepsy , 2002, Expert opinion on investigational drugs.

[7]  E. Mignot,et al.  The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. , 2002, Archives of neurology.

[8]  T. Pollmächer,et al.  Neuroendocrine and metabolic aspects of narcolepsy , 2002 .

[9]  R G Priest,et al.  Prevalence of narcolepsy symptomatology and diagnosis in the European general population , 2002, Neurology.

[10]  C. Shapiro,et al.  The Prevalence, Cost Implications, and Management of Sleep Disorders: An Overview , 2002, Sleep & breathing = Schlaf & Atmung.

[11]  G. Plazzi,et al.  ICSD diagnostic criteria for narcolepsy: interobserver reliability. , 2002 .

[12]  G. Steiner,et al.  Fahrverhalten bei Nakrolepsie-Fragebogenanalyse unter Betroffenen , 2002 .

[13]  S. Nevsimalova,et al.  [Excessive daytime somnolence and its psychosocial sequelae]. , 2002, Sbornik lekarsky.

[14]  M. Littner,et al.  Practice parameters for the treatment of narcolepsy: an update for 2000. , 2001, Sleep.

[15]  I. Smith,et al.  Health‐related quality of life in narcolepsy , 2001, Journal of sleep research.

[16]  M. Littner,et al.  Practice parameters for the evaluation of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine. , 2000, Sleep.

[17]  J. Schulenburg,et al.  Die Standardisierung der Methodik im In- und Ausland , 2000 .

[18]  A E Rogers,et al.  Health-related quality of life effects of modafinil for treatment of narcolepsy. , 1999, Sleep.

[19]  C. Swadling.  Narcolepsy is a rare yet serious disorder. , 1999, Nursing times.

[20]  J M Fry,et al.  Treatment modalities for narcolepsy , 1998, Neurology.

[21]  M. Goswami,et al.  The influence of clinical symptoms on quality of life in patients with narcolepsy , 1998, Neurology.

[22]  Neil J. Douglas.  The psychosocial aspects of narcolepsy , 1998, Neurology.

[23]  Peter Jh.  Economic aspects of sleep medicine , 1996 .

[24]  M Partinen,et al.  Epidemiology of narcolepsy. , 1994, Sleep.

[25]  R. Broughton,et al.  Psychosocial impact of narcolepsy. , 1994, Sleep.

[26]  R. Ernst,et al.  The US economic and social costs of Alzheimer's disease revisited. , 1994, American journal of public health.

[27]  S. Nevsimalova,et al.  [Socioeconomic consequences of narcolepsy. Comparative study of 3 populations in various countries]. , 1987, Ceskoslovenska neurologie a neurochirurgie.

[28]  R. Godbout,et al.  All-day performance variations in normal and narcoleptic subjects. , 1986, Sleep.

[29]  E. Bixler,et al.  Narcolepsy-cataplexy. II. Psychosocial consequences and associated psychopathology. , 1982, Archives of neurology.

[30]  B Roth,et al.  Life Effects of Narcolepsy in 180 Patients from North America, Asia and Europe Compared to Matched Controls , 1981, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.